Clinical Trial Update: Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine) [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 feasibility study evaluating a dapivirine vaginal ring for HIV prevention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dapivirine vaginal ring (TMC120) (dapivirine)

Snippet

Sponsor: International Partnership for Microbicides, Inc. | Conditions: HIV Infections | Phase 1 | Status: COMPLETED